Ekf Diagnostics Share Discussion Threads

[tongosti] 10/6/2022 18:58

You're excused pal - just don't do it again will ya :)

[wan] 10/6/2022 09:34

I genuinely forgot to post this article last week -

Direct-to-Consumer medical testing is something all medical labs should embrace

As more patients request direct-to-consumer (DTC) lab tests, medical laboratories will need to reconfigure and upgrade key aspects of their business in order to serve these new healthcare consumers properly. No longer a pure business-to-business endeavor, labs are now finding themselves in the consumer market.
By J.T. RIPTON

June 1, 2022

As the healthcare industry continues to evolve, medical labs are finding themselves in a unique position. Historically one of the most under-recognized medical specialties, labs are now an essential part of the healthcare equation. According to the Centers for Disease Control and Prevention (CDC), 14 billion lab tests are ordered annually, with 70% of medical decisions dependent on their findings. As such, labs have become the tissue connecting physicians with the information they need to provide quality care.

But healthcare professionals aren’t the only ones ordering lab tests these days. The age of healthcare consumerism is changing the way patients access medical services. This is especially true when it comes to medical testing. Patients who now want more control over their care are taking the initiative and ordering medical tests for themselves.

As more patients request direct-to-consumer (DTC) lab tests, medical laboratories will need to reconfigure and upgrade key aspects of their business in order to serve these new healthcare consumers properly. No longer a pure business-to-business endeavor, labs are now finding themselves in the consumer market. Labs that want to grow and thrive as the paradigm shifts will need to plan accordingly.

Full story and a worthy read for further salient points and insights -


And unlike other labs, ADL should benefit from EKF also being the contract manufacturer for certain direct-to-consumer test kits, not to mention the potential use of proprietary EKF enzymes that can be produced in bulk scale for mass production of such test kits.

[tongosti] 09/6/2022 16:30

I agree on the balance of odds. For a proper recovery you will need wider markets to play ball as well (very tall order this is as chances are we are in the midst of a proper bear market). Hence my earlier comment about playing this over the shorter term.

[p1nkfish] 09/6/2022 15:34

I doubt this is the start of the "recovery proper" which I think we could see start early-mid autumn and back through 40p+.

[tongosti] 09/6/2022 12:01

Likewise pal

[p1nkfish] 09/6/2022 11:43

Each to their own. Enjoy!

[tongosti] 09/6/2022 11:33

Personal choice and all but I have found (been to hell and back, believe me) playing (a lot) for pennies is far safer than aim for the occasional pound. Not unlike predicting weather tomorrow is far safer than 10 years from now. In my view, pennies (when one plays for lots of them) have a way to compound much faster than (mythical) pounds than most would think.

[p1nkfish] 09/6/2022 11:10

So long as you holding is small compared to average daily else your exit will be less than ideally priced. Hold for me as reckon CAGR over 2 years will be attractive but not linear return.

[tongosti] 09/6/2022 09:53

On today's further rise, worth tightening the stop North and riding this on negligible risk. As the wise man said, it's all about timing in the universe we live in.

[wan] 09/6/2022 08:52

Edit to the above post - albeit it's only one among other EKF growth initiatives

[wan] 09/6/2022 08:32

Recall the following - US blood banks: DiaSpect Tm approved by FDA Center for Biologics Evaluation and Research (CBER)

Note that anaemia screening programmes and blood banking initiatives restarted post-pandemic.

Examples -

14 June is World Blood Donor Day


The official website of the US Military Health System -
With this simple act of generosity, you could be saving the life of someone’s brother, sister, parent, or friend. Find out where you can #ReadySetDonate today: militarydonor.com And thank you to all those who have already donated!


EKF's range of hemoglobin analyzers make blood donation and anemia screening easier -


Watch this space (albeit it's only one among other EKF growth initiatives).

[wan] 09/6/2022 07:53

I was impressed with EKF's Link, and todays RNS clearly lays it out as a key differentiator for both new and existing accounts.

This will also apply to new EKF point-of-care devices, or indeed be attractive to new distribution agreements, including private label distribution agreements, such as that already in place with McKesson in the US.

The introduction of EKF's Link connectivity software was one element of EKF's Growth Strategy, which will no doubt also assist the stated diversification and enhancement of their PoC portfolio, including entry into adjacent markets.

Insightful -

[p1nkfish] 09/6/2022 07:27

RNS on EKF Link has landed.

[tongosti] 08/6/2022 14:21

It just doesn't matter the reason why. All that matters is huge volumes showing a great level of interest. Since this is a perception game - volumes are Mr Market's way to tip his hand off. No guarantee of course (anything can happen in this game so managing risk via SL route is key). Wan - there is a time to go long and a time to go short. There is never a time to support one side indefinitely. Granted, it's a tall order pal.

[faz] 08/6/2022 13:53

3m shares traded so far today. A concerted decision by a few players or leaked info? It can wait til tomorrow to see if this is a fluke or not. The company has assets, £20m cash,trades profitably, and has secured a loyal customer base with a strategy for growth. So could attract a bid of around £200-£220m I suppose.

[tongosti] 08/6/2022 13:17

Chart is indeed conducive. Assuming wider markets play ball (big ask in the context of wider macro worries), this is indeed a good risk ward proposition on the long side ( for a change). An exploratory bet with a tight stop is not a bad idea. If it works great - if it doesn't that's what the stop is there for.

[wan] 08/6/2022 11:25

Regarding my final comment in post 2759/2760 - Put another way, highly specialised contract fermentation can apparently produce hard to replicate cannabinoids at commercial scale for consumer applications and pharmacological pipelines, which in turn, like hemp and its derivatives, will also require accurate testing in order to have accurate and appropriate consumer protection labelling, thus staying the right side of the FDA in terms of marketing and authorisation.

'Fermented' food for thought: Specialist cannabinoid production capability along with specialist authorised testing capability would appear to be very complimentary, and would thus appear to represent an attractive fit for companies producing next-generation natural ingredients.

Readers will note in post 2759 that ADL test plant material for Delta-9-THC, THCA and 9 other cannabinoids.

[se81] 08/6/2022 10:29

Looks like the chart is bottoming…

[wan] 07/6/2022 14:50

A free worthwhile, easy to read pdf -

COVID-19 Has Transformed Society: What it Means for Clinical Labs
Posted by Chris Wolski | Jun 6, 2022

Since its declaration as a pandemic in March 2020, COVID-19 has transformed society, particularly attitudes about clinical testing. Even with COVID-19 entering its endemic phase, due to a combination of scientific reality with falling infection numbers in first-world countries, political and economic pressure by citizens and business leaders, and plain, old-fashioned exhaustion, laboratorians and pathologists know that COVID-19 is here to stay no matter the societal pressures designed to “move beyond” the pandemic.

There is little doubt clinical laboratories will remain on the front lines of the fight against COVID. In this CLP-produced eBook you will learn:

How serology has played and will continue to play a key role in identifying and classifying new SARS-CoV-2 mutations, allowing new tests to be developed quickly.
How labs can help clinicians effectively meet COVID testing demands during so-called “flu season” with planning and multiplex testing options.

How clinical laboratories will play a critical role in helping clinicians identify long or chronic COVID conditions that could plague the healthcare system for decades to come.

Clinical Laboratories Remaining Vigilant
Clinical laboratories will remain on the front lines of the fight against COVID.

In the following pages you will learn:
• How serology has played and will continue to play a key role
in identifying and classifying new SARS-CoV-2 mutations,
allowing new tests to be developed quickly.
• How labs can help clinicians effectively meet COVID testing
demands during so-called “flu season” with planning and
multiplex testing options.
• How clinical laboratories will play a critical role in helping
clinicians identify long or chronic COVID conditions that
could plague the healthcare system for decades to come.

It is unclear the long-term effects that COVID will have on society as a whole, but clinical laboratories will undoubtedly continue to play a role in keeping SARS-CoV-2, at worse, an endemic annoyance.
Chris Wolski is chief editor of CLP

[p1nkfish] 07/6/2022 09:00

Good to have that exposure. Legalisation will probably involve potency limits that will need testing for. Havent read the entire post so may already have been mentioned in there.

[wan] 07/6/2022 08:19

Edit to the above post - this will not be EKF's only exposure to cannabis compounds and formulations

[tongosti] 06/6/2022 15:03

Long weekend so nothing to "note" from our resident gambler. What's going on - run out of batteries?